Cholesterol absorption and lipoprotein metabolism in type II diabetes mellitus with and without coronary artery disease

Atherosclerosis

Volumn 126, Issue 2, 1996, Pages 325-332

  Gylling, Helena ^a   Miettinen, Tatu A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cholesterol absorption and synthesis; Coronary artery disease; LDH and HDL kinetics; Plant sterols; Type II diabetes mellitus

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; BIGUANIDE DERIVATIVE; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; HIGH DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0030601714     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05930-8     Document Type: Article

References (45)

1. Kannel WB, McGee DL Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 59:1979;8-13.
2. Stamler J, Wentworth D, Neaton J, Schoenberger JA, Feigal D for the MRFIT Research Group. Diabetes and risk of coronary, cardiovascular, and all causes mortality: findings for 356 000 men screened by the Multiple Risk Factor Intervention Trial (MRFIT). Circulation 1984;70(suppl 2):II-161.
3. DIS Group, Hanefeld M, Schmechel H, Julius Uet al. Five-year incidence of coronary heart disease related to major risk factors and metabolic control in newly diagnosed non-insulin-dependent diabetes. Nutr Metab Cardiovasc Dis. 1:1991;135-140.
4. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation. 82:1990;27-36.
5. Fontbonne AM, Eschwege EM Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 14:1991;461-469.
6. Stern MP, Haffner SM Dyslipidemia in type II diabetes. Implications for therapeutic intervention. Diabetes Care. 14:1991;1144-1159.
7. Ginsberg HN Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care. 14:1991;839-855.
8. Reaven GM Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. Metabolism. 36((suppl I)):1987;1-8.
9. Schonfeld G, Birge C, Miller JP, Kessler G, Santiago J Apolipoprotein B levels and altered lipoprotein composition in diabetes. Diabetes. 23:1974;827-834.
10. Iwai M, Yoshino G, Matsushita Met al. Abnormal lipoprotein composition in normolipidemic diabetic patients. Diabetes Care. 13:1990;792-796.
11. Stewart MW, Laker MF, Dyer RGet al. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb. 13:1993;1046-1052.
12. Feingold KR, Grunfeld C, Pang M, Doerrler W, Krauss RM LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb. 12:1992;1496-1502.
13. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM Low density lipoprotein sub-class patterns and risk of myocardial infarction. J Am Med Assoc. 260:1988;1917-1921.
14. Hiramatsu K, Arimori S Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes. 37:1988;832-837.
15. Lopes-Virella MF, Klein RL, Lyons TJ, Stevenson HC, Witztum JL Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocytederived macrophages. Diabetes. 37:1988;550-557.
16. Steinbrecher UP, Witztum JL Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes. 33:1984;130-134.
17. Miettinen TA Cholesterol metabolism in patients with coronary heart disease. Ann Clin Res. 3:1971;313-322.
18. Simonen H, Miettinen TA Coronary artery disease and bile acid synthesis in familial hypercholesterolemia. Atherosclerosis. 63:1987;159-166.
19. Kesäniemi YA, Grundy SM Overproduction of low density lipoproteins associated with coronary heart disease. Arteriosclerosis. 3:1983;40-46.
20. Knuts L-R, Rastas M, Haapala P. Micro-Nutrica. Version 1.0. Helsinki:Kansaneläkelaitos, 1991.
21. 3) when used as an index substance. Science. 116:1952;634-635.
22. Crouse JR, Grundy SM Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man. J Lipid Res. 19:1978;967-971.
23. Miettinen TA Gas-liquid chromatographic determination of fecal neutral sterols using a capillary column. Clin Chim Acta. 124:1982;245-248.
24. Miettinen TA, Ahrens EH Jr., Grundy SM Quantitative isolation and gas-liquid chromatographic analysis of total dietary and fecal neutral steroids. J Lipid Res. 6:1965;411-424.
25. Grundy SM, Ahrens EH Jr., Miettinen TA Quantitative isolation and gas-liquid chromatographic analysis of total fecal bile acids. J Lipid Res. 6:1965;397-410.
26. Lipid and Lipoprotein Analysis. Manual of Laboratory Operations, Lipid Research Clinic Program. Washington D.C.: DHEW Publication No NIH/75-628. 1974:63-70.
27. Gylling H, Vanhanen H, Miettinen TA Effects of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia. J Lipid Res. 34:1993;59-67.
28. Havekes LM, de Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E A rapid micromethod for apolipoprotein E phenotyping directly in serum. J Lipid Res. 28:1987;445-463.
29. Catignoni GL, Bieri JG Simultaneous determination of retinol and alpha-tocopherol in serum or plasma by liquid chromatography. Clin Chem. 29:1983;708-712.
30. Vega GL, Gylling H, Nichols AV, Grundy SM Evaluation of a method for study of kinetics of autologous apolipoprotein A-I. J Lipid Res. 32:1991;867-875.
31. McFarlane AS Efficient trace-labeling of proteins with iodine. Nature. 182:1958;53.
32. Bilheimer DW, Eisenberg S, Levy RI The metabolism of very low density lipoproteins. I. Preliminary in vitro and in vivo observations Biochim Biophys Acta. 260:1972;212-221.
33. Gylling H, Miettinen TA Non-cholesterol sterols, absorption and synthesis of cholesterol and apolipoprotein A-I kinetics in a Finnish lecithin-cholesterol acyltransferase deficient family. Atherosclerosis. 95:1992;25-33.
34. 131I]-labeled plasma proteins. Phys Med Biol. 2:1957;36-53.
35. Miettinen TA, Tilvis RS, Kesäniemi YA Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 131:1990;20-31.
36. Kesäniemi YA, Ehnholm C, Miettinen TA Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest. 80:1987;578-581.
37. Gertler MM, Woodbury MA, Gottsch LG, White PD, Rusk HA The candidate for coronary heart disease - discriminating power of biochemical hereditary and anthropometric measurements. J Am Med Assoc. 170:1959;149-152.
38. Miettinen TA, Lampainen E, Penttilä IM Familial occurrence of mild hyperlipoproteinaemias. Clin Genet. 3:1972;271-280.
39. Miettinen TA, Aro A Faecal fat, bile acid excretion, and body height in familial hypercholesterolaemia and hyperglyceridaemia. Scand J Clin Lab Invest. 30:1972;85-88.
40. Zanni EE, Zannis VI, Blum CB, Herbert PN, Breslow JL Effect of egg cholesterol and dietary fats on plasma lipids, lipoproteins, and apoproteins of normal women consuming natural diets. J Lipid Res. 28:1987;518-527.
41. Miettinen TA, Kesäniemi YA Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr. 49:1989;629-635.
42. Quintao E, Grundy SM, Ahrens EH Jr. Effects of dietary cholesterol on the regulation of total body cholesterol in man. J Lipid Res. 12:1971;233-247.
43. Shekelle RB, Stamler J Dietary cholesterol and ischaemic heart disease. Lancet. I:1989;1177-1179.
44. Miettinen TA, Strandberg T, Vanhanen H, Gylling H, for the 4S Group. Non-cholesterol serum sterols in Scandinavian Simvastatin Survival Study. XII International Symposium on Drugs Affecting Lipid Metabolism, November 7-10, 1995 Houston Texas. Abstracts, p. 34.
45. Gylling H, Miettinen TA Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia. 37:1994;773-780.